Dr. Clay Siegall: CEO of Seattle Genetics

Dr. Clay Siegall is the Chief Executive Officer and founder of Seattle Genetics. Clay ventured on the biotechnology industry after observing several families fall victims to the untimely demise of members of their household to diseases that have no cure. Such diseases are usually accountable for regulation of population numbers especially in countries with very high numbers of the population. Seattle Genetics is a biotechnology industry that has majored in laboratory preparation and development of specific target therapy drugs that are aimed at countering the effect of the highly dangerous diseases. Dr. Clay Siegall is a well equipped with enough knowledge when it comes to the field of genetics. He has a good educational background. He holds a bachelor degree in Zoology from the University of Maryland and also a doctorate in Genetics from George Washington University. Dr. Clay founded Seattle Genetics in 1998. He has since then proved competent enough for the work as he has gradually led Seattle Genetics to the top of targeted therapy industry.

Dr. Clay is well recognized for developing of the FDA- approved antibody drug conjugate. He has also developed several other drugs while making partnerships in his career to boost his products. During his time as manager, Seattle Genetics has transformed from a mere business project to a booming biotechnology firm. The total number of employees has also been increased to cater for the increased duties within the firm. All the employees are employed by experience and knowledge as this involves people’s health. Dr. Siegall is one who understands that success has no limits. With an increased number of drugs in the development pipeline, Seattle Genetics is poised to move into the 21st century in a more commanding state.

Since time immemorial, the use of systemic chemo-therapies in cancer has dominated in medical institutions. However, according to Dr. Clay Siegall, he feels that they are now out-dated and should be dispatched away. As the efficiency of targeted drugs starts taking root, it will reach a point where more sustainable methods shall be used instead of old therapies. Dr. Clay Siegall believes that for you to be successful in anything you do, then you must be driven by passion.